Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 3, 1996, Pages 268-272

  Fleming, C ^a   Hull, M G R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HUMAN; HYDROSALPINX; MAJOR CLINICAL STUDY; NIDATION; PREGNANCY RATE; PRIORITY JOURNAL;

ADULT; EDEMA; EMBRYO IMPLANTATION; FALLOPIAN TUBE DISEASES; FEMALE; FERTILIZATION IN VITRO; HUMANS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SALPINGITIS; TREATMENT OUTCOME;

EID: 0029916840     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09717.x     Document Type: Article

References (31)

1. Mansour RT, Aboulghar MA, Serour GI, Riad R. Fluid accumulation of the uterine cavity before embryo transfer: A possible hindrance for implantation. Journal of In Vitro Fertilisation-Embryo Transfer 1991; 8: 157-159.
2. Tan SL, Royston P, Campbell S et al. Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet 1992; 339: 1390-1394.
3. Haan G, Bernardus RE, Hollanders JMG et al. Results of IVF from a prospective multicentre study. Hum Reprod 1991; 6: 805-810.
4. HFEA (UK Human Fertilisation and Embryo logy Authority). Annual report. London : HFEA.
5. FIVNAT. In-vitro fertilization: Influence of women’s age on pregnancy rates. Hum Reprod 1990; 5: 56-59.
6. Hull MGR, Fleming CF, Hughes AO, McDermott A. The age-related decline in female fecundity: A quantitative controlled study of implanting capacity and survival of individual embryo s after in vitro fertilization. Fertil Steril 1996. In press.
7. FIVNAT. French national IVF registry analysis of 1986 to 1990 data. Fertil Steril 1993; 59: 587-595.
8. Hull MGR, Eddowes HA, Fahy U et al. Expectations of assisted conception for infertility. BMJ 1992; 304: 1465-1469.
9. Fleming CF, Hughes AO, Williams JA, Ford WCL, Hull MGR. Effect of cause of infertility on success during IVF. Hum Reprod 1994; 9(4Suppl): 117.
10. Bowman MC, Cooke ID, Lenton EA. Investigation of impaired ovarian function as a contributing factor to infertility in women with pelvic adhesions. Hum Reprod 1993; 8: 1654-1656.
11. Richmond SJ, Caul EO. Flourescent antibody studies in chlamydia1 infections. J Clin Microbiol 1975; 1: 345-352.
12. FIVNAT. Infecondites inexpliquees bilan FIVNAT 1986-199I. Contracept Fertil Sex 1992; 20: 821-823.
13. FIVNAT. French national IVF registry analysis of 1986 to 1990 data. Fertil Steril 1993; 59: 587-595.
14. Fleming CF, McDermott A, Hull MGR. Impaired implantation associated with hydrosalpinges. J Reprod Ferril Abstr Ser 1994; 14:5.
15. Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod 1994; 9: 861-863.
16. Anderson AN, Yue Z, Meng FJ, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod 1994; 9: 1935-1938.
17. Vandromme J, Chasse E, Lejeune B, Van Rysselberge M, Delvigne A, Leroy F. Hydrosalpinges in in-vitro fertilization: An unfavourable prognostic feature. Hum Reprod 1995; 10: 576-579.
18. Hershlag A, Kaplan EH, Loy RA et al. Heterogeneity in patient populations explains differences in in vitro fertilization programs. Fertil Steril 1991; 56: 913-917.
19. Lejeune B, Vandromme J, Delvigne A. Lower implantation rate in IVF tuba1 indications [abstract]. Proceedings of the 7th World Congress on IVF and Assisted Procreation; Paris. 1991: 407.
20. Sims JA, Jones D, Butler L, Muasher SJ. Effect of hydrosalpinx on outcome in in vitro fertilisation (IVF) [abstract]. In: Proceedings of the American Fertility Society Meeting; 11-14 October, 1993; Montreal. 1993: 95.
21. Edwards RG. Why are agonadal and post-amenorrhoeic women so fertile after oocyte donation Hum Reprod 1992; 7: 733-734.
22. Sauer MV, Paulson RJ, Lobo RA. Pregnancy after fifty: Application of oocyte donation to women after natural menopause. Lancet 1993; 341: 321-323.
23. Abdalla HI, Burton G, Kirkland A et al. Age, pregnancy and miscarriage: uterine versus ovarian factors. Hum Reprod 1993; 8: 1512-1517.
24. Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993; 69: 9-17.
25. Conway D, Caul EO, Hull MGR et al. Chlamydia1 serology in fertile and infertile women. Lancet 1984; 1: 191-193.
26. Tasdemir I, Tasdemir M, Kodama H, Sekine K, Tanaka T. Effect of chlamydial antibodies on the outcome of in vitro fertilization (IVF) treatment. J Assist Reprod Genet 1994; 11: 104-106.
27. Driscoll GL, Dodd J, Tyler JP, Howard B, Lamont B, Coles R. Positive chlamydial serology and its effect on factors influencing outcome of IVF treatment. Aust NZJ Obstet Gynaecol 1991; 31: 145-147.
28. Osser S, Persson K, Wramsby H, Liedholm P. Does previous Chlamydia trachomatis infection influence the pregnancy rate of in vitro fertilization and embryo replacement Am J Obstet Gynecol 1990; 162: 40-44.
29. Torode HW, Wheeler PA, Saunders DM, McPetrie RA, Medcalf SC, Ackerman VP. The role of chlamydial antibodies in an in vitro program. Fertil Steril 1987; 48: 987.
30. Aboulghar MA, Mansour RT, Serour GI, Sattar MA, Awad MA, Amin Y. Transvaginal ultrasonic needle guided aspiration of pelvic inflammatory cystic masses before ovulation induction for in vitro fertilisation. Fertil Steril 1990; 53: 311-314.
31. Russell JB, Rodriguez Z, Komins JY. The use of transvaginal ultrasound to aspirate bilateral hydrosalpinges prior to in vitro fertilization: A case report. Journal of In Vitro Fertilization-Embryo Transfer 1991; 8: 213-215.